Matthew Jackson

Matthew Jackson's work experience begins in 2003, where they worked as a Floor Manager at McDonald's Corporation until 2011. Matthew then became a PhD Research Student and later a Laboratory Teacher and UCAS Ambassador at the University of Sheffield from 2010 to 2014. Following this, they served as a Postdoctoral Research Fellow at the University of Leeds from 2014 to 2018, focusing on the study of proteins associated with Parkinson's disease and dialysis-related amyloidosis. From 2018 to 2020, they worked as a Postdoctoral Research Associate at the ARUK ALBORADA Drug Discovery Institute. Currently, Matthew is employed at Bicycle Therapeutics, where they have held multiple roles, including Senior Scientist from 2020 to 2022, Team Leader - Protein & Cellular Sciences from 2022 to 2022, and currently as the Associate Director - Protein & Cellular Sciences. Matthew manages a team of scientists and is responsible for protein and cell-based reagent generation as well as the development of antigen/target over expressing cell lines. Matthew also supported the move of the Biology team into new premises, including the design of new labs and equipment purchases.

Matthew Jackson has a strong educational background in the field of sciences. Matthew obtained their Doctor of Philosophy (PhD) degree in Biochemistry from The University of Sheffield, where they studied from 2010 to 2014. Before that, they completed a degree in Chemistry, specifically a Master's degree (MChem), also from The University of Sheffield, from 2006 to 2010. Prior to their university studies, Matthew attended Tuxford Comprehensive School from 1999 to 2006, although no specific degree or field of study is mentioned. Additionally, Matthew has a certification in Biological Safety: Management and Practice (IOSH Approved) from the institution IOSH, which they obtained in September 2020.